Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan D Tward

Showing results (41-50 of 71) with videos related to

Pageof 8
Sort By:
Journal of Radiosurgery and SBRT|January 4, 2018
Stereotactic radiosurgery for a single brain metastasis: factors impacting controlAaron E Wagner, Andy Chen, Christopher J Anker, et al.
Ear, Nose, & Throat Journal|June 19, 2008
Gorham disease of the mandible: radiographic findings and radiotherapy responseThomas B Skidmore, Christopher M Lee, Thomas M Abbott, et al.
JCO Precision Oncology|July 12, 2021
Clinical Germline Testing Results of Men With Prostate Cancer: Patient-Level Factors and Implications of NCCN Guideline ExpansionSamantha E Greenberg, Trevor C Hunt, Jacob P Ambrose, et al.
JCO Precision Oncology|May 15, 2024
Using the Cell-Cycle Risk Score to Predict the Benefit of Androgen-Deprivation Therapy Added to Radiation Therapy in Patients With Newly Diagnosed Prostate CancerJonathan D Tward, Lauren Lenz, Alexander Gutin, et al.
Clinical Genitourinary Cancer|June 16, 2021
Temporal Trends and Predictors in Diagnosing Pathologic Node-Positive Prostate Cancer in Clinically Node-Negative PatientsRyan J Hutten, Matthew W Parsons, Christopher R Weil, et al.
Urology|February 27, 2007
Prostate-specific antigen control with low-dose adjuvant radiotherapy for high-risk prostate cancerO Kenneth Macdonald, R Jeffrey Lee, Greg Snow, et al.
BJU International|July 30, 2016
Management of Radiation Therapy Oncology Group grade 4 urinary adverse events after radiotherapy for prostate cancerErik N Mayer, Jonathan D Tward, Mitchell Bassett, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|September 4, 2007
Planned neck dissection after definitive radiotherapy or chemoradiation for base of tongue cancersYing J Hitchcock, Brandon G Bentz, Pramod K Sharma, et al.
The Journal of Urology|September 21, 2013
Climacturia after definitive treatment of prostate cancerBrock B O'Neil, Angela Presson, John Gannon, et al.
Cancer Medicine|February 22, 2023
Secondary malignancies in non-Hodgkin lymphoma survivors: 40 years of follow-up assessed by treatment modalityMatthew W Parsons, Calvin Rock, Jonathan J Chipman, et al.
Pageof 8

Showing results (41-50 of 71) with videos related to

Sort By:
Pageof 8
Journal of Radiosurgery and SBRT|January 4, 2018
Stereotactic radiosurgery for a single brain metastasis: factors impacting controlAaron E Wagner, Andy Chen, Christopher J Anker, et al.
Ear, Nose, & Throat Journal|June 19, 2008
Gorham disease of the mandible: radiographic findings and radiotherapy responseThomas B Skidmore, Christopher M Lee, Thomas M Abbott, et al.
JCO Precision Oncology|July 12, 2021
Clinical Germline Testing Results of Men With Prostate Cancer: Patient-Level Factors and Implications of NCCN Guideline ExpansionSamantha E Greenberg, Trevor C Hunt, Jacob P Ambrose, et al.
JCO Precision Oncology|May 15, 2024
Using the Cell-Cycle Risk Score to Predict the Benefit of Androgen-Deprivation Therapy Added to Radiation Therapy in Patients With Newly Diagnosed Prostate CancerJonathan D Tward, Lauren Lenz, Alexander Gutin, et al.
Clinical Genitourinary Cancer|June 16, 2021
Temporal Trends and Predictors in Diagnosing Pathologic Node-Positive Prostate Cancer in Clinically Node-Negative PatientsRyan J Hutten, Matthew W Parsons, Christopher R Weil, et al.
Urology|February 27, 2007
Prostate-specific antigen control with low-dose adjuvant radiotherapy for high-risk prostate cancerO Kenneth Macdonald, R Jeffrey Lee, Greg Snow, et al.
BJU International|July 30, 2016
Management of Radiation Therapy Oncology Group grade 4 urinary adverse events after radiotherapy for prostate cancerErik N Mayer, Jonathan D Tward, Mitchell Bassett, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|September 4, 2007
Planned neck dissection after definitive radiotherapy or chemoradiation for base of tongue cancersYing J Hitchcock, Brandon G Bentz, Pramod K Sharma, et al.
The Journal of Urology|September 21, 2013
Climacturia after definitive treatment of prostate cancerBrock B O'Neil, Angela Presson, John Gannon, et al.
Cancer Medicine|February 22, 2023
Secondary malignancies in non-Hodgkin lymphoma survivors: 40 years of follow-up assessed by treatment modalityMatthew W Parsons, Calvin Rock, Jonathan J Chipman, et al.
Pageof 8